2013 annual financial data
PTC Therapeutics 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -149.79%.
Operating income was -45,397,469 USD and net income was -51,573,575 USD.
Operating cash flow was -46,922,124 USD.
Get free PTC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 31,326,117 USD
- Operating income
- -45,397,469 USD
- Net income
- -51,573,575 USD
- Operating cash flow
- -46,922,124 USD